A new study provides direct evidence for the role of the Notch pathway in breast cancer stem cell activity as demonstrated by a Notch reporter system. Notch signaling regulates embryonic and tissue-specific stem cells, which are altered in a number of cancers, including breast cancer.
A new study characterizes the genetic underpinnings of a rare type of breast tumor called phyllodes tumors, offering the first comprehensive analysis of the molecular alterations at work in these tumors.
Daniel F. Hayes, M.D., clinical director of the breast oncology program at the University of Michigan Comprehensive Cancer Center, was elected president of the American Society of Clinical Oncology, the largest and one of the most influential oncology professional societies.
New guidelines based on decades of clinical trials give guidance about which complementary therapies appear to be most effective and safe for breast cancer patients. More than 80 therapies were evaluated and assigned a letter grade.
Donning pink along with the rest of the crowd at the Rockefeller Center plaza in Manhattan and aside former Good Morning America host and breast cancer survivor Joan Lunden, Newman discussed advances in research and treatment.
QVC and FFANY presented a check for $342,143 to the Cancer Center's Breast Oncology Program, one of nine beneficiaries of the 2013 QVC Presents "FFANY Shoes on Sale" event, in which 75,000 pairs of shoes were ordered at half the manufacturer’s suggested retail price, all in the name of cancer awareness.
The second annual Maize and Blue Go Pink gala will be Aug. 21 at the Somerset Collection. The evening includes a fashion-focused live auction followed by a progressive culinary and wine experience from favorite Detroit and Ann Arbor restaurants. It all benefits breast cancer research at the U-M Comprehensive Cancer Center.